HK1043736B - 含抗黃體素及黃體素之避孕組合物 - Google Patents

含抗黃體素及黃體素之避孕組合物

Info

Publication number
HK1043736B
HK1043736B HK02104868.9A HK02104868A HK1043736B HK 1043736 B HK1043736 B HK 1043736B HK 02104868 A HK02104868 A HK 02104868A HK 1043736 B HK1043736 B HK 1043736B
Authority
HK
Hong Kong
Prior art keywords
substituted
alkyl
aminoalkyl
alkoxy
alkynyl
Prior art date
Application number
HK02104868.9A
Other languages
English (en)
Other versions
HK1043736A1 (en
Inventor
S Grubb Gary
Zhi Lin
K Jones Todd
M Tegley Christopher
P Edwards James
A Fletcher Horace
E Wrobel Jay
Fensome Andrew
Zhang Puwen
A Terefenko Eugene
Original Assignee
Wyeth Corp
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,350 external-priority patent/US6444668B1/en
Application filed by Wyeth Corp, Ligand Pharm Inc filed Critical Wyeth Corp
Publication of HK1043736A1 publication Critical patent/HK1043736A1/xx
Publication of HK1043736B publication Critical patent/HK1043736B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
HK02104868.9A 1999-05-04 2002-06-28 含抗黃體素及黃體素之避孕組合物 HK1043736B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30471299A 1999-05-04 1999-05-04
US09/552,350 US6444668B1 (en) 1999-05-04 2000-04-19 Combination regimens using progesterone receptor modulators
PCT/US2000/011643 WO2000066164A1 (en) 1999-05-04 2000-05-01 Contraceptive compositions containing antiprogestinic and progestinic

Publications (2)

Publication Number Publication Date
HK1043736A1 HK1043736A1 (en) 2002-09-27
HK1043736B true HK1043736B (zh) 2005-04-01

Family

ID=26974177

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104868.9A HK1043736B (zh) 1999-05-04 2002-06-28 含抗黃體素及黃體素之避孕組合物

Country Status (14)

Country Link
EP (1) EP1173210B1 (zh)
JP (1) JP2002543155A (zh)
CN (1) CN1179753C (zh)
AT (1) ATE275973T1 (zh)
AU (1) AU4682000A (zh)
CA (1) CA2372773A1 (zh)
DE (1) DE60013798T2 (zh)
DK (1) DK1173210T3 (zh)
ES (1) ES2226833T3 (zh)
HK (1) HK1043736B (zh)
MX (1) MXPA01011311A (zh)
PT (1) PT1173210E (zh)
SI (1) SI1173210T1 (zh)
WO (1) WO2000066164A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1699A (en) 2001-03-21 2006-12-26 Warner Lambert Co New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
JP2006508076A (ja) 2002-10-11 2006-03-09 リガンド・ファーマシューティカルズ・インコーポレイテッド 選択的プロゲステロン受容体モジュレーター化合物としての５−シクロアルケニル５Ｈ−クロメノ［３，４−ｆ］キノリン誘導体
JP2006504736A (ja) 2002-10-11 2006-02-09 リガンド・ファーマシューティカルズ・インコーポレイテッド 選択的プロゲステロンレセプター調節化合物としての５−（１’，１’−シクロアルキル／アルケニル）メチリデン１，２−ジヒドロ−５Ｈ−クロメノ［３，４−ｆ］キノリン
AR047398A1 (es) 2003-11-24 2006-01-18 Wyeth Corp Acoplamiento cruzado carbono- carbono catalizado por metales de transicion sobre soportes solidos
CN1953967B (zh) * 2004-04-27 2013-03-13 惠氏公司 孕酮受体调节剂的纯化
WO2006023158A2 (en) 2004-07-14 2006-03-02 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds
WO2006010142A2 (en) 2004-07-14 2006-01-26 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds, processes for their preparation, and their use
EP1774970A1 (de) * 2005-10-13 2007-04-18 Bayer Schering Pharma AG Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE4330234A1 (de) * 1993-09-02 1995-03-09 Schering Ag Verwendung von Gestagenen und kompetitiven Progesteronantagonisten zur Herstellung von Arzneimitteln für die weibliche Fertilitätskontrolle sowie Mittel enthaltend ein Gestagen und einen kompetitiven Progesteronantagonisten
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
ATE264106T1 (de) * 1994-11-22 2004-04-15 Balance Pharmaceuticals Inc Verfahren zur empfängnisverhütung
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
NZ332894A (en) * 1996-06-25 1999-05-28 Akzo Nobel Nv A regimen containing progestogen and/or estrogen with two or more anti-progestogen dosage units

Also Published As

Publication number Publication date
AU4682000A (en) 2000-11-17
HK1043736A1 (en) 2002-09-27
PT1173210E (pt) 2005-01-31
DE60013798T2 (de) 2005-09-29
DE60013798D1 (de) 2004-10-21
CN1179753C (zh) 2004-12-15
MXPA01011311A (es) 2003-07-14
WO2000066164A8 (en) 2001-05-03
WO2000066164A1 (en) 2000-11-09
ES2226833T3 (es) 2005-04-01
ATE275973T1 (de) 2004-10-15
CA2372773A1 (en) 2000-11-09
DK1173210T3 (da) 2005-01-24
JP2002543155A (ja) 2002-12-17
EP1173210A1 (en) 2002-01-23
SI1173210T1 (en) 2005-02-28
EP1173210B1 (en) 2004-09-15
CN1349415A (zh) 2002-05-15

Similar Documents

Publication Publication Date Title
WO2000066165A8 (en) Contraceptive compositions containing quinazolinone and benzoxazine derivatives
DK1175398T3 (da) Indolinderivater som progesteronantagonister
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
CY1105688T1 (el) Κυανοπυρρολες ως αγωνιστες υποδοχεων προγεστερονης
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
PE20010613A1 (es) Antagonistas de la hormona concentradora de la melanina
MX9504349A (es) Derivados de aroilpiperidina.
WO2000066103A3 (en) Contraceptive compositions containing cyclic urea and amide derivatives
HUP0400250A2 (hu) 5-HT6 és/vagy 5-HT7 szerotonin receptorok ligandumaként alkalmazott 5-halogén-triptamin-származékok, előállításuk és alkalmazásuk gyógyszerkészítmények előállítására
WO2000066225A8 (en) Contraceptive compositions containing cyclic carbamates and amide derivatives
HK1043736A1 (en) Contraceptive compositions containing antiprogestinic and progestinic.
BR0311593A (pt) Derivados de 1-sulfonil-4-aminoalcoxi indol como moduladores de receptor 5-ht6 para tratamento dos distúrbios de snc
NO973243L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer
BR9811769A (pt) Tetraidro gama-carbolinas
HUP0203332A2 (hu) Ciklotiokarbamát-származékok, progeszteron receptor modulátorokként való alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ATE460412T1 (de) Trisubstituierte thiophene als progesteronreceptor-modulatoren
TWI265032B (en) Pharmaceutically useful kits comprising progesterone receptor modulators
EA200101180A1 (ru) Производные тио-оксиндола
SI1809602T1 (sl) Indolni derivati, uporabni kot modulatorji progesteronskega receptorja
BR0010213A (pt) Derivados de ciclocarbamato como moduladores de receptor de progesterona
AR024549A1 (es) Uso de moduladores de progesterona del receptor de progesterona y kit farmaceutica para regimenes ciclicos
AR023854A1 (es) Uso de derivados de indolina y equipo farmaceutico para regimenes ciclicos
RU97113497A (ru) Применение 3,4-дифенилхроманов для получения фармацевтической композиции для лечения или профилактики гинекологических заболеваний
GEP20043221B (en) Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Pharmaceutical Composition Containing Them and Use Thereof for Treatment Progesterone-Related Maladies.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080501